Cargando…
Delayed Hepatocellular Carcinoma Recurrence After Liver Transplantation: Comprehensive Clinical Characterization of Case Series
PURPOSE: Liver transplantation (LT) is the definite curative treatment for hepatocellular carcinoma (HCC), but recurrence can occur even under stringent criteria. “Delayed” HCC recurrence (>3 years after LT) is not common. Here, we present the clinical features of patients who developed delayed H...
Autores principales: | Wong, Ta-Hsiang, Ho, Cheng-Maw, Hsu, Hsao-Hsun, Wu, Yao-Ming, Ho, Ming-Chih, Lee, Po-Huang, Hu, Rey-Heng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9586169/ https://www.ncbi.nlm.nih.gov/pubmed/36275405 http://dx.doi.org/10.2147/JHC.S383474 |
Ejemplares similares
-
Prophylactic liver transplantation for high-risk recurrent hepatocellular carcinoma
por: Yang, Po-Chih, et al.
Publicado: (2016) -
Cross-Match as an Immuno-Oncological Risk Factor for Hepatocellular Carcinoma Recurrence and Inferior Survival After Living Donor Liver Transplantation: A Call for Further Investigation
por: Ho, Cheng-Maw, et al.
Publicado: (2020) -
Long-Term Survival in Patients With T2 Hepatocellular Carcinoma After Primary Curative Resection Can Be Further Stratified by Tumor Size
por: Ho, Cheng-Maw, et al.
Publicado: (2014) -
Post-Transplant Malignancy in Liver Transplantation: A Single Center Experience
por: Hsiao, Chih-Yang, et al.
Publicado: (2014) -
Survival After Treatable Hepatocellular Carcinoma Recurrence in Liver Recipients: A Nationwide Cohort Analysis
por: Ho, Cheng-Maw, et al.
Publicado: (2021)